user

IMMUNOHISTOCHEMICAL DEMONSTRATION OF RAS P21 ONCOGENE PRODUCT IN NORMAL, BENIGN, AND MALIGNANT HUMAN THYROID TISSUES

被引：0
|
作者：
MIZUKAMI, Y
NONOMURA, A
HASHIMOTO, T
TERAHATA, S
MATSUBARA, F
MICHIGISHI, T
NOGUCHI, M
机构：
[1] KANAZAWA UNIV,SCH MED,CENT CLIN LAB,KANAZAWA,ISHIKAWA 920,JAPAN
[2] KANAZAWA UNIV,SCH MED,DEPT NUCL MED,KANAZAWA,ISHIKAWA 920,JAPAN
[3] KANAZAWA UNIV,SCH MED,DEPT SURG,KANAZAWA,ISHIKAWA 920,JAPAN
[4] KANAZAWA UNIV,SCH MED,DEPT PATHOL,KANAZAWA,ISHIKAWA 920,JAPAN
来源：
CANCER | 1988年 / 61卷 / 05期
关键词：
D O I：
10.1002/1097-0142(19880301)61:5<873::AID-CNCR2820610504>3.0.CO;2-W
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：873 / 880
页数：8
相关论文
共 50 条
  • [41] ras p21 immunohistochemical detection in human endometrial carcinomas
    Semczuk, A
    Miturski, R
    Baranowski, W
    Jakowicki, JA
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1997, 44 (02) : 132 - 135
  • [42] AFFINITY LABELING OF RAS ONCOGENE PRODUCT P21 WITH GUANOSINE DIPHOSPHOPYRIDOXALS AND TRIPHOSPHOPYRIDOXALS
    OHMI, N
    HOSHINO, M
    TAGAYA, M
    FUKUI, T
    KAWAKITA, M
    HATTORI, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1988, 263 (28) : 14261 - 14266
  • [43] THE RAS ONCOGENE PRODUCT P21 IS NOT A REGULATORY COMPONENT OF ADENYLATE-CYCLASE
    BECKNER, SK
    HATTORI, S
    SHIH, TY
    NATURE, 1985, 317 (6032) : 71 - 72
  • [44] IMMUNOHISTOCHEMICAL DETECTION OF THE C-ERBB-2 PROTO-ONCOGENE PRODUCT IN NORMAL, BENIGN AND MALIGNANT CARTILAGE TISSUES
    WRBA, F
    GULLICK, WJ
    FERTL, H
    AMANN, G
    SALZERKUNTSCHIK, M
    HISTOPATHOLOGY, 1989, 15 (01) : 71 - 76
  • [45] IMMUNOHISTOCHEMICAL ANALYSIS OF RAS ONCOGENE-P21 PRODUCT IN HUMAN GASTRIC CARCINOMAS AND THEIR ADJACENT MUCOSAS
    CARNEIRO, F
    DAVID, L
    SUNKEL, C
    LOPES, C
    SOBRINHOSIMOES, M
    PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (03) : 263 - 272
  • [46] Evaluation of c-RAS oncogene product (p21) in superficial bladder cancer
    Fontana, D
    Bellina, M
    Scoffone, C
    Cagnazzi, E
    Cappia, S
    Cavallo, F
    Russo, R
    Leonardo, E
    EUROPEAN UROLOGY, 1996, 29 (04) : 470 - 476
  • [47] Immunohistochemical expression of ras p21 in human salivary gland neoplasms
    Zhu, JQ
    Tipoe, GL
    White, FH
    JOURNAL OF PATHOLOGY, 1997, 181 : A40 - A40
  • [48] IMMUNOHISTOCHEMICAL STUDY OF ONCOGENE PRODUCT RAS P21, C-MYC AND GROWTH-FACTOR EGF IN BREAST CARCINOMAS
    MIZUKAMI, Y
    NONOMURA, A
    NOGUCHI, M
    TANIYA, T
    KOYASAKI, N
    SAITO, Y
    HASHIMOTO, T
    MATSUBARA, F
    YANAIHARA, N
    ANTICANCER RESEARCH, 1991, 11 (04) : 1485 - 1494
  • [49] IMMUNOCYTOCHEMICAL DEMONSTRATION OF RAS P21 IN HUMAN-BREAST CANCER
    QUERZOLI, P
    MARCHETTI, E
    BAGNI, A
    MARZOLA, A
    FABRIS, G
    NENCI, I
    ANTICANCER RESEARCH, 1986, 6 (03) : 386 - 386
  • [50] ANTIBODIES TO RAS ONCOGENE P21 PROTEINS LACK IMMUNOHISTOCHEMICAL SPECIFICITY FOR NEOPLASTIC EPITHELIUM IN HUMAN-PROSTATE TISSUE
    VARMA, VA
    AUSTIN, GE
    OCONNELL, AC
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1989, 113 (01) : 16 - 19
12345